{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:02:17Z","timestamp":1774681337389,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Acute intermittent porphyria (AIP) is a rare genetic disorder that affects porphyrin metabolism in the blood. The disease causes defects in specific enzymes in the body, which in turn leads to the accumulation of porphyrin metabolites. Patients may experience abdominal pain, neurological symptoms, muscle pain, and nausea, but it does not directly cause pancreatitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The patient is a young woman, 23 years old, who was admitted to our hospital with intermittent abdominal pain for 2 days, the pain was not fixed, episodic, with no obvious trigger, and 1 day before admission, the patient started to experience nausea and vomiting, with gastric contents as the vomitus, and similar symptoms had occurred many times in the past. Blood amylase 600 U\/L, blood sodium 120.6 mmol\/L, blood routine, and coagulation function results were normal; abdominal CT showed pancreatic swelling with unclear surrounding fat interstitial, acute pancreatitis was considered. The patient\u2019s urine was dark red, and the results of the qualitative urine porphyrin test were positive.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>AIP complicated with acute pancreatitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>Relief of symptoms, control of pain, correction of electrolyte disturbances, and high-carbohydrate therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient was discharged with complete symptomatic relief after 10 days of high-carbohydrate therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>AIP complicated with acute pancreatitis is very rare. Treatment of AIPs aims to control acute attacks and prevent potential triggers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036036","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:21:36Z","timestamp":1701163296000},"page":"e36036","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Acute intermittent porphyria complicated with acute pancreatitis: A case report and literature review"],"prefix":"10.1097","volume":"102","author":[{"given":"Cheng","family":"Jiao","sequence":"first","affiliation":[{"name":"Department of General Surgery, Bethune International Peace Hospital, Shijiazhuang, Hebei 050000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2851-5750","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Bethune International Peace Hospital, Shijiazhuang, Hebei 050000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Bethune International Peace Hospital, Shijiazhuang, Hebei 050000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Bethune International Peace Hospital, Shijiazhuang, Hebei 050000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ming","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Bethune International Peace Hospital, Shijiazhuang, Hebei 050000, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MOG.0000000000000734","article-title":"Novel treatment options for acute hepatic porphyrias.","volume":"37","author":"Wang","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/antiox9111109","article-title":"Hemin prevents increased glycolysis in macrophages upon activation: protection by microbiota-derived metabolites of polyphenols.","volume":"9","author":"Carrasco-Pozo","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"R3-20250504","first-page":"e34757","article-title":"A case of acute intermittent porphyria leading to severe disability in a young 21-year-old female.","volume":"15","author":"Ramzan","year":"2023","journal-title":"Cureus"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13023-020-01375-y","article-title":"Reversible splenial lesion syndrome (RESLES) due to acute intermittent porphyria with a novel mutation in the hydroxymethylbilane synthase gene.","volume":"15","author":"Yang","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"R5-20250504","first-page":"100842","article-title":"Long-term follow-up of acute porphyria in female patients: update of clinical outcome and life expectancy.","volume":"30","author":"Baumann","year":"2022","journal-title":"Mol Genet Metab Rep"},{"key":"R6-20250504","first-page":"1051","article-title":"Consensus of Chinese porphyria diagnosis and treatment experts (2020).","volume":"100","author":"Zhang","year":"2020","journal-title":"Nat Med J China"},{"key":"R7-20250504","first-page":"e36058","article-title":"Acute intermittent porphyria\u2019s symptoms and management: a narrative review.","volume":"15","author":"Kizilaslan","year":"2023","journal-title":"Cureus"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2169\/internalmedicine.56.7654","article-title":"Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome, accompanied by prolonged vasoconstriction.","volume":"56","author":"Takata","year":"2017","journal-title":"Intern Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/cei.12899","article-title":"Systemic inflammation in acute intermittent porphyria: a case-control study.","volume":"187","author":"Storjord","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"R10-20250504","first-page":"8","article-title":"Clinical characteristics and treatment analysis of acute intermittent porphyria patients in China.","volume":"25","author":"Li","year":"2022","journal-title":"Chin Gen Prac"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.clinph.2011.07.036","article-title":"Purple pigments: the pathophysiology of acute porphyric neuropathy.","volume":"122","author":"Lin","year":"2011","journal-title":"Clin Neurophysiol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0447.1994.tb01511.x","article-title":"Acute intermittent porphyria and mental illness--a family study.","volume":"89","author":"Patience","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"R13-20250504","first-page":"3109","article-title":"Advances in research on acute intermittent hematoporphyria.","volume":"23","author":"Li","year":"2020","journal-title":"Chin Gen Practice"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/00016340903390729","article-title":"Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria.","volume":"89","author":"Innala","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R15-20250504","first-page":"99","article-title":"An audit of the use of Gonadorelin analogues to prevent recurrent acute symptoms in patients with acute porphyria in the United Kingdom.","volume":"36","author":"Schulenburg-Brand","year":"2017","journal-title":"JIMD Rep"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/BJ20111005","article-title":"ALAS1 gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FOXO1 by vanadate in diabetic mice.","volume":"442","author":"Oliveri","year":"2012","journal-title":"Biochem J"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/excr.1998.4206","article-title":"Insulin inhibits delta-aminolevulinate synthase gene expression in rat hepatocytes and human hepatoma cells.","volume":"244","author":"Scassa","year":"1998","journal-title":"Exp Cell Res"},{"key":"R18-20250504","first-page":"426","article-title":"Acute intermittent porphyria and glucose metabolism.","volume":"41","author":"Li","year":"2022","journal-title":"Int J Endocrinol Metab"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jhep.2019.05.003","article-title":"Current and innovative emerging therapies for porphyrias with hepatic involvement.","volume":"71","author":"Fontanellas","year":"2019","journal-title":"J Hepatol"},{"key":"R20-20250504","first-page":"868","article-title":"Gene therapy for acute intermittent porphyria.","volume":"38","author":"Li","year":"2018","journal-title":"Chin J Digestion"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of RNAi therapeutic Givosiran for acute intermittent porphyria.","volume":"382","author":"Balwani","year":"2020","journal-title":"N Engl J Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/17512433.2022.2075848","article-title":"Givosiran for the treatment of acute hepatic porphyria.","volume":"15","author":"Ricci","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2147\/TCRM.S180161","article-title":"Acute intermittent porphyria: current perspectives and case presentation.","volume":"15","author":"Spiritos","year":"2019","journal-title":"Ther Clin Risk Manag"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:01:46Z","timestamp":1746345706000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":23,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036036","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}